MustGrow: Seasoned Social Impact Financier Barry Palte Appointed To Advisory Board

MustGrow Biologics (CSE: MGRO) this morning announced that it has strengthened its advisory team. The company has appointed seasoned global social impact financier Barry Palte to its advisory team, whom is expected to leverage his deep global relationships in agriculture tech to support the rollout of MustGrow’s mustard derived technology.

Palte has spent his career focusing on impact investing within disruptive companies that have a major impact on the health of both people and the planet. His investment projects must commit explicitly to these beliefs. With MustGrow focused on producing a natural, organic, and science-based solutions for high-value crops, and taking on synthetic chemical producers in the process, the firm is a natural fit for Palte.

Barry Palte has had an extensive career in executive management, with over 35 years worth of experience in management, funds management, investment and investment banking. His experience includes serving as the Global Chairman of the International Association of Investment Bankers, while also being an invited member of Top Tier Impact. Further, he has spent the last 21 years of his career as the founder of globally focused EQ Capital Partners.

"I am delighted to be joining the MustGrow team to assist with their mission of developing and deploying highly effective crop protection solutions that are safe for our natural environment and the consumers and workers who rely on a safe global food system. The world is facing incredible trials at the moment, from financial to medical and environmental. Key to solving these challenges is connecting the right investment capital and partners to the highest impact companies and projects, at speed and on a global basis. I look forward to supporting the passionate and committed MustGrow team with my global networks." 
Barry Palte

In connection with the appointment, MustGrow has issued 650,000 common share purchase warrants. Each warrant is valid for a period of 2 years from the date of issuance, with an exercise price of $0.35 per share.

MustGrow Biologics last traded at $0.39 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

MustGrow Biologics: NexusBioAg Partnership Validates Firms Research Program

Among current trends, governments around the world are banning the use of harmful pesticides and...

Monday, May 24, 2021, 02:16:00 PM

MustGrow Biologics Files Patents For Bio-Herbicide

MustGrow Biologics Corp (CSE: MGRO) announced this morning that it has filed a number of...

Monday, January 27, 2020, 08:57:52 AM

MustGrow Biologics Closes Financing At Final Figure Of $7.1 Million

MustGrow Biologics (CSE: MGRO) this morning closed off its previously announced private placement financing. The...

Thursday, October 7, 2021, 07:52:23 AM

MustGrow Biologics More Than Triples Financing To $6.9 Million Due To Demand

Demand within the natural biopesticide space from investors appears to be extremely strong. MustGrow Biologics...

Wednesday, September 29, 2021, 08:21:37 AM

Bayer, US Government Behind Thailand’s Glyphosate Ban Reversal

It appears that Bayer and the US government may have been undertaking some shady lobbying...

Sunday, September 20, 2020, 03:41:00 PM